APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urinary and Pelvic Floor Health Solution

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Urinary and Pelvic Floor Health Solution Market Analysis and Forecast 2026-2032

2 May 2026244 pages

Choose your research edition.

Industry ResearchUrinary and Pelvic Floor Health Solution Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Urinary and Pelvic Floor Health Solution Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Urinary and Pelvic Floor Health Solution Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urinary and Pelvic Floor Health Solution Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Urinary and Pelvic Floor Health Solution Market Analysis and Forecast 2026-2032244 pages · $4,950 USD

Market perspective

The global Urinary and Pelvic Floor Health Solution market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Urinary and Pelvic Floor Health Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Urinary and Pelvic Floor Health Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Urinary and Pelvic Floor Health Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Urinary and Pelvic Floor Health Solution is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Urinary and Pelvic Floor Health Solution include Peloton Health, Elvie, Renovia, InControl Medical, PeriCoach, NeoTract, NextGen Jane, Hollister Incorporated and Zimmer Biomet, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Urinary and Pelvic Floor Health Solution, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Urinary and Pelvic Floor Health Solution, also provides the revenue of main regions and countries. Of the upcoming market potential for Urinary and Pelvic Floor Health Solution, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Urinary and Pelvic Floor Health Solution revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Urinary and Pelvic Floor Health Solution market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Urinary and Pelvic Floor Health Solution revenue, projected growth trends, production technology, application and end-user industry.

Urinary and Pelvic Floor Health Solution Segment by Company

Peloton Health

Elvie

Renovia

InControl Medical

PeriCoach

NeoTract

NextGen Jane

Hollister Incorporated

Zimmer Biomet

Joylux

Medtronic

Atlantic Therapeutics

Boston Scientific

Urinary and Pelvic Floor Health Solution Segment by Type

Urology and Pelvic Floor Health Software

Urology and Pelvic Floor Health Service

Urinary and Pelvic Floor Health Solution Segment by Application

Male

Female

Urinary and Pelvic Floor Health Solution Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urinary and Pelvic Floor Health Solution market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urinary and Pelvic Floor Health Solution and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urinary and Pelvic Floor Health Solution.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Urinary and Pelvic Floor Health Solution in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Urinary and Pelvic Floor Health Solution company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urinary and Pelvic Floor Health Solution revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Urinary and Pelvic Floor Health Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Urology and Pelvic Floor Health Software Major Player Table 3. Urology and Pelvic Floor Health Service Major Player Table 4. Global Urinary and Pelvic Floor Health Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Male Major Player Table 6. Female Major Player Table 7. Urinary and Pelvic Floor Health Solution Industry Trends Table 8. Urinary and Pelvic Floor Health Solution Industry Drivers Table 9. Urinary and Pelvic Floor Health Solution Industry Opportunities and Challenges Table 10. Urinary and Pelvic Floor Health Solution Industry Restraints Table 11. Global Urinary and Pelvic Floor Health Solution Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Urinary and Pelvic Floor Health Solution Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Urinary and Pelvic Floor Health Solution Market Share by Region (2021-2026) Table 14. Global Urinary and Pelvic Floor Health Solution Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Urinary and Pelvic Floor Health Solution Market Share by Region (2027-2032) Table 16. Global Urinary and Pelvic Floor Health Solution Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Players (2021-2026) Table 18. Global Urinary and Pelvic Floor Health Solution Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Urinary and Pelvic Floor Health Solution Key Players Headquarters & Area Served Table 20. Global Urinary and Pelvic Floor Health Solution Players, Product Type & Application Table 21. Global Urinary and Pelvic Floor Health Solution Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Urinary and Pelvic Floor Health Solution by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Urinary and Pelvic Floor Health Solution Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Type (2021-2026) Table 28. Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Type (2027-2032) Table 29. Global Urinary and Pelvic Floor Health Solution Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Application (2021-2026) Table 33. Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Application (2027-2032) Table 34. Peloton Health Company Information Table 35. Peloton Health Business Overview Table 36. Peloton Health Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Peloton Health Urinary and Pelvic Floor Health Solution Product Portfolio Table 38. Peloton Health Recent Development Table 39. Elvie Company Information Table 40. Elvie Business Overview Table 41. Elvie Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Elvie Urinary and Pelvic Floor Health Solution Product Portfolio Table 43. Elvie Recent Development Table 44. Renovia Company Information Table 45. Renovia Business Overview Table 46. Renovia Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Renovia Urinary and Pelvic Floor Health Solution Product Portfolio Table 48. Renovia Recent Development Table 49. InControl Medical Company Information Table 50. InControl Medical Business Overview Table 51. InControl Medical Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. InControl Medical Urinary and Pelvic Floor Health Solution Product Portfolio Table 53. InControl Medical Recent Development Table 54. PeriCoach Company Information Table 55. PeriCoach Business Overview Table 56. PeriCoach Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. PeriCoach Urinary and Pelvic Floor Health Solution Product Portfolio Table 58. PeriCoach Recent Development Table 59. NeoTract Company Information Table 60. NeoTract Business Overview Table 61. NeoTract Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. NeoTract Urinary and Pelvic Floor Health Solution Product Portfolio Table 63. NeoTract Recent Development Table 64. NextGen Jane Company Information Table 65. NextGen Jane Business Overview Table 66. NextGen Jane Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. NextGen Jane Urinary and Pelvic Floor Health Solution Product Portfolio Table 68. NextGen Jane Recent Development Table 69. Hollister Incorporated Company Information Table 70. Hollister Incorporated Business Overview Table 71. Hollister Incorporated Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 72. Hollister Incorporated Urinary and Pelvic Floor Health Solution Product Portfolio Table 73. Hollister Incorporated Recent Development Table 74. Zimmer Biomet Company Information Table 75. Zimmer Biomet Business Overview Table 76. Zimmer Biomet Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 77. Zimmer Biomet Urinary and Pelvic Floor Health Solution Product Portfolio Table 78. Zimmer Biomet Recent Development Table 79. Joylux Company Information Table 80. Joylux Business Overview Table 81. Joylux Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (US$ Million) & (2021-2026) Table 82. Joylux Urinary and Pelvic Floor Health Solution Product Portfolio Table 83. Joylux Recent Development Table 84. Medtronic Company Information Table 85. Medtronic Business Overview Table 86. Medtronic Urinary and Pelvic Floor Health Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 87. Medtronic Urinary and Pelvic Floor Health Solution Product Portfolio Table 88. Medtronic Recent Development Table 89. Atlantic Therapeutics Company Information Table 90. Atlantic Therapeutics Business Overview Table 91. Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 92. Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Product Portfolio Table 93. Atlantic Therapeutics Recent Development Table 94. Boston Scientific Company Information Table 95. Boston Scientific Business Overview Table 96. Boston Scientific Urinary and Pelvic Floor Health Solution Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 97. Boston Scientific Urinary and Pelvic Floor Health Solution Product Portfolio Table 98. Boston Scientific Recent Development Table 99. North America Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026) & (US$ Million) Table 100. North America Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032) & (US$ Million) Table 101. North America Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Urinary and Pelvic Floor Health Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 104. North America Urinary and Pelvic Floor Health Solution Revenue by Country (2021-2026) & (US$ Million) Table 105. North America Urinary and Pelvic Floor Health Solution Revenue by Country (US$ Million) & (2027-2032) Table 106. Europe Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026) & (US$ Million) Table 107. Europe Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032) & (US$ Million) Table 108. Europe Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026) & (US$ Million) Table 109. Europe Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032) & (US$ Million) Table 110. Europe Urinary and Pelvic Floor Health Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Europe Urinary and Pelvic Floor Health Solution Revenue by Country (2021-2026) & (US$ Million) Table 112. Europe Urinary and Pelvic Floor Health Solution Revenue by Country (US$ Million) & (2027-2032) Table 113. China Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026) & (US$ Million) Table 114. China Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032) & (US$ Million) Table 115. China Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026) & (US$ Million) Table 116. China Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032) & (US$ Million) Table 117. Asia Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026) & (US$ Million) Table 118. Asia Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032) & (US$ Million) Table 119. Asia Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026) & (US$ Million) Table 120. Asia Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032) & (US$ Million) Table 121. Asia Urinary and Pelvic Floor Health Solution Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 122. Asia Urinary and Pelvic Floor Health Solution Revenue by Region (US$ Million) & (2021-2026) Table 123. Asia Urinary and Pelvic Floor Health Solution Revenue by Region (US$ Million) & (2027-2032) Table 124. SAMEA Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026) & (US$ Million) Table 125. SAMEA Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032) & (US$ Million) Table 126. SAMEA Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026) & (US$ Million) Table 127. SAMEA Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032) & (US$ Million) Table 128. SAMEA Urinary and Pelvic Floor Health Solution Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 129. SAMEA Urinary and Pelvic Floor Health Solution Revenue by Country (2021-2026) & (US$ Million) Table 130. SAMEA Urinary and Pelvic Floor Health Solution Revenue by Country (US$ Million) & (2027-2032) Table 131. Research Programs/Design for This Report Table 132. Authors List of This Report Table 133. Secondary Sources Table 134. Primary Sources List of Figures Figure 1. Urinary and Pelvic Floor Health Solution Image Figure 2. Global Urinary and Pelvic Floor Health Solution Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urinary and Pelvic Floor Health Solution Market Size Share 2021 VS 2025 VS 2032 Figure 4. Urology and Pelvic Floor Health Software Image Figure 5. Urology and Pelvic Floor Health Service Image Figure 6. Global Urinary and Pelvic Floor Health Solution Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Urinary and Pelvic Floor Health Solution Market Size Share 2021 VS 2025 VS 2032 Figure 8. Male Image Figure 9. Female Image Figure 10. Global Urinary and Pelvic Floor Health Solution Market Size (US$ Million) & (2021-2032) Figure 11. Global Urinary and Pelvic Floor Health Solution Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Urinary and Pelvic Floor Health Solution Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Urinary and Pelvic Floor Health Solution Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Urinary and Pelvic Floor Health Solution Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Urinary and Pelvic Floor Health Solution Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Type (2021-2032) Figure 18. Global Urinary and Pelvic Floor Health Solution Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Application (2021-2032) Figure 21. North America Urinary and Pelvic Floor Health Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Urinary and Pelvic Floor Health Solution Revenue Share by Type (2021-2032) Figure 23. North America Urinary and Pelvic Floor Health Solution Revenue Share by Application (2021-2032) Figure 24. North America Urinary and Pelvic Floor Health Solution Revenue Share by Country (2021-2032) Figure 25. United States Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Urinary and Pelvic Floor Health Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Urinary and Pelvic Floor Health Solution Revenue Share by Type (2021-2032) Figure 30. Europe Urinary and Pelvic Floor Health Solution Revenue Share by Application (2021-2032) Figure 31. Europe Urinary and Pelvic Floor Health Solution Revenue Share by Country (2021-2032) Figure 32. Germany Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Urinary and Pelvic Floor Health Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Urinary and Pelvic Floor Health Solution Revenue Share by Type (2021-2032) Figure 42. China Urinary and Pelvic Floor Health Solution Revenue Share by Application (2021-2032) Figure 43. Asia Urinary and Pelvic Floor Health Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Urinary and Pelvic Floor Health Solution Revenue Share by Type (2021-2032) Figure 45. Asia Urinary and Pelvic Floor Health Solution Revenue Share by Application (2021-2032) Figure 46. Asia Urinary and Pelvic Floor Health Solution Revenue Share by Region (2021-2032) Figure 47. Japan Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Urinary and Pelvic Floor Health Solution Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Urinary and Pelvic Floor Health Solution Revenue Share by Type (2021-2032) Figure 55. SAMEA Urinary and Pelvic Floor Health Solution Revenue Share by Application (2021-2032) Figure 56. SAMEA Urinary and Pelvic Floor Health Solution Revenue Share by Country (2021-2032) Figure 57. Brazil Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Urinary and Pelvic Floor Health Solution Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Urology and Pelvic Floor Health Software
  • Urology and Pelvic Floor Health Service
Applications
  • Male
  • Female
Companies covered
  • Peloton Health
  • Elvie
  • Renovia
  • InControl Medical
  • PeriCoach
  • NeoTract
  • NextGen Jane
  • Hollister Incorporated
  • Zimmer Biomet
  • Joylux
  • Medtronic
  • Atlantic Therapeutics
  • Boston Scientific

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Urinary and Pelvic Floor Health Solution Market by Type
  3. 1.2.1 Global Urinary and Pelvic Floor Health Solution Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Urology and Pelvic Floor Health Software
  5. 1.2.3 Urology and Pelvic Floor Health Service
  6. 1.3 Urinary and Pelvic Floor Health Solution Market by Application
  7. 1.3.1 Global Urinary and Pelvic Floor Health Solution Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Male
  9. 1.3.3 Female
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Urinary and Pelvic Floor Health Solution Market Dynamics
  1. 2.1 Urinary and Pelvic Floor Health Solution Industry Trends
  2. 2.2 Urinary and Pelvic Floor Health Solution Industry Drivers
  3. 2.3 Urinary and Pelvic Floor Health Solution Industry Opportunities and Challenges
  4. 2.4 Urinary and Pelvic Floor Health Solution Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Urinary and Pelvic Floor Health Solution Market Perspective (2021-2032)
  2. 3.2 Global Urinary and Pelvic Floor Health Solution Growth Trends by Region
  3. 3.2.1 Global Urinary and Pelvic Floor Health Solution Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Urinary and Pelvic Floor Health Solution Market Size by Region (2021-2026)
  5. 3.2.3 Global Urinary and Pelvic Floor Health Solution Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Urinary and Pelvic Floor Health Solution Revenue by Players
  2. 4.1.1 Global Urinary and Pelvic Floor Health Solution Revenue by Players (2021-2026)
  3. 4.1.2 Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Urinary and Pelvic Floor Health Solution Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Urinary and Pelvic Floor Health Solution Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Urinary and Pelvic Floor Health Solution Key Players Headquarters & Area Served
  7. 4.4 Global Urinary and Pelvic Floor Health Solution Players, Product Type & Application
  8. 4.5 Global Urinary and Pelvic Floor Health Solution Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Urinary and Pelvic Floor Health Solution Market CR5 and HHI
  11. 4.6.3 2025 Urinary and Pelvic Floor Health Solution Tier 1, Tier 2, and Tier 3
5 Urinary and Pelvic Floor Health Solution Market Size by Type
  1. 5.1 Global Urinary and Pelvic Floor Health Solution Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2032)
  3. 5.3 Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Type (2021-2032)
6 Urinary and Pelvic Floor Health Solution Market Size by Application
  1. 6.1 Global Urinary and Pelvic Floor Health Solution Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2032)
  3. 6.3 Global Urinary and Pelvic Floor Health Solution Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Peloton Health
  2. 7.1.1 Peloton Health Company Information
  3. 7.1.2 Peloton Health Business Overview
  4. 7.1.3 Peloton Health Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Peloton Health Urinary and Pelvic Floor Health Solution Product Portfolio
  6. 7.1.5 Peloton Health Recent Developments
  7. 7.2 Elvie
  8. 7.2.1 Elvie Company Information
  9. 7.2.2 Elvie Business Overview
  10. 7.2.3 Elvie Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Elvie Urinary and Pelvic Floor Health Solution Product Portfolio
  12. 7.2.5 Elvie Recent Developments
  13. 7.3 Renovia
  14. 7.3.1 Renovia Company Information
  15. 7.3.2 Renovia Business Overview
  16. 7.3.3 Renovia Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Renovia Urinary and Pelvic Floor Health Solution Product Portfolio
  18. 7.3.5 Renovia Recent Developments
  19. 7.4 InControl Medical
  20. 7.4.1 InControl Medical Company Information
  21. 7.4.2 InControl Medical Business Overview
  22. 7.4.3 InControl Medical Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  23. 7.4.4 InControl Medical Urinary and Pelvic Floor Health Solution Product Portfolio
  24. 7.4.5 InControl Medical Recent Developments
  25. 7.5 PeriCoach
  26. 7.5.1 PeriCoach Company Information
  27. 7.5.2 PeriCoach Business Overview
  28. 7.5.3 PeriCoach Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  29. 7.5.4 PeriCoach Urinary and Pelvic Floor Health Solution Product Portfolio
  30. 7.5.5 PeriCoach Recent Developments
  31. 7.6 NeoTract
  32. 7.6.1 NeoTract Company Information
  33. 7.6.2 NeoTract Business Overview
  34. 7.6.3 NeoTract Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  35. 7.6.4 NeoTract Urinary and Pelvic Floor Health Solution Product Portfolio
  36. 7.6.5 NeoTract Recent Developments
  37. 7.7 NextGen Jane
  38. 7.7.1 NextGen Jane Company Information
  39. 7.7.2 NextGen Jane Business Overview
  40. 7.7.3 NextGen Jane Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  41. 7.7.4 NextGen Jane Urinary and Pelvic Floor Health Solution Product Portfolio
  42. 7.7.5 NextGen Jane Recent Developments
  43. 7.8 Hollister Incorporated
  44. 7.8.1 Hollister Incorporated Company Information
  45. 7.8.2 Hollister Incorporated Business Overview
  46. 7.8.3 Hollister Incorporated Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  47. 7.8.4 Hollister Incorporated Urinary and Pelvic Floor Health Solution Product Portfolio
  48. 7.8.5 Hollister Incorporated Recent Developments
  49. 7.9 Zimmer Biomet
  50. 7.9.1 Zimmer Biomet Company Information
  51. 7.9.2 Zimmer Biomet Business Overview
  52. 7.9.3 Zimmer Biomet Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Zimmer Biomet Urinary and Pelvic Floor Health Solution Product Portfolio
  54. 7.9.5 Zimmer Biomet Recent Developments
  55. 7.10 Joylux
  56. 7.10.1 Joylux Company Information
  57. 7.10.2 Joylux Business Overview
  58. 7.10.3 Joylux Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Joylux Urinary and Pelvic Floor Health Solution Product Portfolio
  60. 7.10.5 Joylux Recent Developments
  61. 7.11 Medtronic
  62. 7.11.1 Medtronic Company Information
  63. 7.11.2 Medtronic Business Overview
  64. 7.11.3 Medtronic Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  65. 7.11.4 Medtronic Urinary and Pelvic Floor Health Solution Product Portfolio
  66. 7.11.5 Medtronic Recent Developments
  67. 7.12 Atlantic Therapeutics
  68. 7.12.1 Atlantic Therapeutics Company Information
  69. 7.12.2 Atlantic Therapeutics Business Overview
  70. 7.12.3 Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Atlantic Therapeutics Urinary and Pelvic Floor Health Solution Product Portfolio
  72. 7.12.5 Atlantic Therapeutics Recent Developments
  73. 7.13 Boston Scientific
  74. 7.13.1 Boston Scientific Company Information
  75. 7.13.2 Boston Scientific Business Overview
  76. 7.13.3 Boston Scientific Urinary and Pelvic Floor Health Solution Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Boston Scientific Urinary and Pelvic Floor Health Solution Product Portfolio
  78. 7.13.5 Boston Scientific Recent Developments
8 North America
  1. 8.1 North America Urinary and Pelvic Floor Health Solution Revenue (2021-2032)
  2. 8.2 North America Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2032)
  3. 8.2.1 North America Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026)
  4. 8.2.2 North America Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032)
  5. 8.3 North America Urinary and Pelvic Floor Health Solution Revenue Share by Type (2021-2032)
  6. 8.4 North America Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2032)
  7. 8.4.1 North America Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026)
  8. 8.4.2 North America Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032)
  9. 8.5 North America Urinary and Pelvic Floor Health Solution Revenue Share by Application (2021-2032)
  10. 8.6 North America Urinary and Pelvic Floor Health Solution Revenue by Country
  11. 8.6.1 North America Urinary and Pelvic Floor Health Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Urinary and Pelvic Floor Health Solution Revenue by Country (2021-2026)
  13. 8.6.3 North America Urinary and Pelvic Floor Health Solution Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Urinary and Pelvic Floor Health Solution Revenue (2021-2032)
  2. 9.2 Europe Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2032)
  3. 9.2.1 Europe Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026)
  4. 9.2.2 Europe Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032)
  5. 9.3 Europe Urinary and Pelvic Floor Health Solution Revenue Share by Type (2021-2032)
  6. 9.4 Europe Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2032)
  7. 9.4.1 Europe Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026)
  8. 9.4.2 Europe Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032)
  9. 9.5 Europe Urinary and Pelvic Floor Health Solution Revenue Share by Application (2021-2032)
  10. 9.6 Europe Urinary and Pelvic Floor Health Solution Revenue by Country
  11. 9.6.1 Europe Urinary and Pelvic Floor Health Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Urinary and Pelvic Floor Health Solution Revenue by Country (2021-2026)
  13. 9.6.3 Europe Urinary and Pelvic Floor Health Solution Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Urinary and Pelvic Floor Health Solution Revenue (2021-2032)
  2. 10.2 China Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2032)
  3. 10.2.1 China Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026)
  4. 10.2.2 China Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032)
  5. 10.3 China Urinary and Pelvic Floor Health Solution Revenue Share by Type (2021-2032)
  6. 10.4 China Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2032)
  7. 10.4.1 China Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026)
  8. 10.4.2 China Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032)
  9. 10.5 China Urinary and Pelvic Floor Health Solution Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Urinary and Pelvic Floor Health Solution Revenue (2021-2032)
  2. 11.2 Asia Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2032)
  3. 11.2.1 Asia Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026)
  4. 11.2.2 Asia Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032)
  5. 11.3 Asia Urinary and Pelvic Floor Health Solution Revenue Share by Type (2021-2032)
  6. 11.4 Asia Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2032)
  7. 11.4.1 Asia Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026)
  8. 11.4.2 Asia Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032)
  9. 11.5 Asia Urinary and Pelvic Floor Health Solution Revenue Share by Application (2021-2032)
  10. 11.6 Asia Urinary and Pelvic Floor Health Solution Revenue by Country
  11. 11.6.1 Asia Urinary and Pelvic Floor Health Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Urinary and Pelvic Floor Health Solution Revenue by Country (2021-2026)
  13. 11.6.3 Asia Urinary and Pelvic Floor Health Solution Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Urinary and Pelvic Floor Health Solution Revenue (2021-2032)
  2. 12.2 SAMEA Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Urinary and Pelvic Floor Health Solution Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Urinary and Pelvic Floor Health Solution Revenue by Type (2027-2032)
  5. 12.3 SAMEA Urinary and Pelvic Floor Health Solution Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Urinary and Pelvic Floor Health Solution Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Urinary and Pelvic Floor Health Solution Revenue by Application (2027-2032)
  9. 12.5 SAMEA Urinary and Pelvic Floor Health Solution Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Urinary and Pelvic Floor Health Solution Revenue by Country
  11. 12.6.1 SAMEA Urinary and Pelvic Floor Health Solution Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Urinary and Pelvic Floor Health Solution Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Urinary and Pelvic Floor Health Solution Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst